Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMSP0502BK05 Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1500.93 C74H136N2O28
LMSP0502BK03 Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1444.87 C70H128N2O28
LMSP0502BF01 Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1550.86 C72H130N2O33
LMSP0502BB03 GalNAcalpha1-3GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1688.97 C80H144N4O33
LMSP0502AQ08 GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1689 C82H148N2O33
LMSP0502AY03 Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1890 C86H155NO43
LMSP0502BF07 Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1660.97 C80H144N2O33
LMSP0502AO08 Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1323.86 C68H125NO23
LMSP0502BC02 GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1457.86 C70H127N3O28
LMSP0502BA03 Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1444.87 C70H128N2O28
LMSP0502AS02 GlcNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1254.78 C62H114N2O23
LMSP0502AV08 GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 2079.16 C98H174N4O42
LMSP0502AV07 GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 2051.13 C96H170N4O42
LMSP0502AV06 GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 2081.18 C98H176N4O42
LMSP0502AV02 GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1969.05 C90H160N4O42
LMSP0502AV01 GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1941.02 C88H156N4O42
LMSP0502AO01 Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1185.72 C58H107NO23
LMSP0502BB05 GalNAcalpha1-3GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1745.03 C84H152N4O33
LMSP0502BA02 Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1416.83 C68H124N2O28
LMSP0502AF03 Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1647.94 C78H141N3O33
LMSP0502AU06 Fucalpha1-2Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1471.94 C74H137NO27
LMSP0502AP05 GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1500.93 C74H136N2O28
LMSP0502AF05 Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1704.01 C82H149N3O33
LMSP0502BE02 GalNAcalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1619.91 C76H137N3O33
LMSP0502BC07 GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1539.94 C76H137N3O28
LMSP0502BN07 GalNAcbeta1-3(Fucalpha2-3Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1848.05 C88H157N3O37
LMSP0502BN06 GalNAcbeta1-3(Fucalpha2-3Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1878.1 C90H163N3O37
LMSP0502BN05 GalNAcbeta1-3(Fucalpha2-3Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1850.07 C88H159N3O37
LMSP0502BJ01 Galbeta1-3(Fucalpha2-3GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1737.94 C80H143N3O37
LMSP0502BI06 Fucalpha2-3(Galbeta1-4)GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1878.1 C90H163N3O37
LMSP0502BI01 Fucalpha2-3(Galbeta1-4)GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1737.94 C80H143N3O37
LMSP0502BH08 Fucalpha2-3GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1714.03 C84H151N3O32
LMSP0502BH03 Fucalpha2-3GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1631.95 C78H141N3O32
LMSP0502AF06 Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1732.04 C84H153N3O33
LMSP0502AF07 Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1701.99 C82H147N3O33
LMSP0502BF02 Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1578.89 C74H134N2O33
LMSP0502BL05 GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1704.01 C82H149N3O33
LMSP0502BE01 GalNAcalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1591.88 C74H133N3O33
LMSP0502AO07 Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1295.83 C66H121NO23
LMSP0502AY04 Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1918.03 C88H159NO43
LMSP0502BM04 Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1618.95 C78H142N2O32
LMSP0502BI07 Fucalpha2-3(Galbeta1-4)GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1848.05 C88H157N3O37
LMSP0502AF08 Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1730.02 C84H151N3O33
LMSP0502AG01 Galbeta1-3(Galbeta1-4GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1753.93 C80H143N3O38
LMSP0502AG02 Galbeta1-3(Galbeta1-4GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1781.97 C82H147N3O38
LMSP0502BJ08 Galbeta1-3(Fucalpha2-3GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1876.08 C90H161N3O37
LMSP0502BB02 GalNAcalpha1-3GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1660.94 C78H140N4O33
LMSP0502AQ07 GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1660.97 C80H144N2O33
LMSP0502BG08 Galbeta1-4GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1730.02 C84H151N3O33
LMSP0502BE07 GalNAcalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1701.99 C82H147N3O33